Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells

Lidia De Felice, Caterina Tatarelli, Maria Grazia Mascolo, Chiara Gregorj, Francesca Agostini, Roberto Fiorini, Vania Gelmetti, Simona Pascale, Fabrizio Padula, Maria Teresa Petrucci, William Arcese, Clara Nervi

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

Ex vivo amplification of human hematopoietic stem cells (HSC) without loss of their self-renewing potential represents an important target for transplantation, gene and cellular therapies. Valproic acid is a safe and widely used neurologic agent that acts as a potent inhibitor of histone deacetylase activities. Here, we show that valproic acid addition to liquid cultures of human CD34+ cells isolated from cord blood, mobilized peripheral blood, and bone marrow strongly enhances the ex vivo expansion potential of different cytokine cocktails as shown by morphologic, cytochemical, immunophenotypical, clonogenic, and gene expression analyses. Notably, valproic acid highly preserves the CD34 positivity after 1 week (range, 40-89%) or 3 weeks (range, 21-52%) amplification cultures with two (Flt3L + thrombopoietin) or four cytokines (Flt3L + thrombopoietin + stem cell factor + interleukin 3). Moreover, valproic acid treatment increases histone H4 acetylation levels at specific regulatory sites on HOXB4, a transcription factor gene with a key role in the regulation of HSC self-renewal and AC133, a recognized marker gene for stem cell populations. Overall, our results relate the changes induced by valproic acid on chromatin accessibility with the enhancement of the cytokine effect on the maintenance and expansion of a primitive hematopoietic stem cell population. These findings underscore the potentiality of novel epigenetic approaches to modify HSC fate in vitro.

Original languageEnglish
Pages (from-to)1505-1513
Number of pages9
JournalCancer Research
Volume65
Issue number4
DOIs
Publication statusPublished - Feb 15 2005

Fingerprint

Histone Deacetylase Inhibitors
Valproic Acid
Hematopoietic Stem Cells
Cytokines
Thrombopoietin
Stem Cell Factor
Interleukin-3
Acetylation
Fetal Blood
Epigenomics
Genetic Therapy
Histones
Nervous System
Population
Genes
Chromatin
Transcription Factors
Stem Cells
Transplantation
Bone Marrow

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

De Felice, L., Tatarelli, C., Mascolo, M. G., Gregorj, C., Agostini, F., Fiorini, R., ... Nervi, C. (2005). Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Research, 65(4), 1505-1513. https://doi.org/10.1158/0008-5472.CAN-04-3063

Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. / De Felice, Lidia; Tatarelli, Caterina; Mascolo, Maria Grazia; Gregorj, Chiara; Agostini, Francesca; Fiorini, Roberto; Gelmetti, Vania; Pascale, Simona; Padula, Fabrizio; Petrucci, Maria Teresa; Arcese, William; Nervi, Clara.

In: Cancer Research, Vol. 65, No. 4, 15.02.2005, p. 1505-1513.

Research output: Contribution to journalArticle

De Felice, L, Tatarelli, C, Mascolo, MG, Gregorj, C, Agostini, F, Fiorini, R, Gelmetti, V, Pascale, S, Padula, F, Petrucci, MT, Arcese, W & Nervi, C 2005, 'Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells', Cancer Research, vol. 65, no. 4, pp. 1505-1513. https://doi.org/10.1158/0008-5472.CAN-04-3063
De Felice, Lidia ; Tatarelli, Caterina ; Mascolo, Maria Grazia ; Gregorj, Chiara ; Agostini, Francesca ; Fiorini, Roberto ; Gelmetti, Vania ; Pascale, Simona ; Padula, Fabrizio ; Petrucci, Maria Teresa ; Arcese, William ; Nervi, Clara. / Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. In: Cancer Research. 2005 ; Vol. 65, No. 4. pp. 1505-1513.
@article{fe5a1fe6053d461ab034248a54f290e7,
title = "Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells",
abstract = "Ex vivo amplification of human hematopoietic stem cells (HSC) without loss of their self-renewing potential represents an important target for transplantation, gene and cellular therapies. Valproic acid is a safe and widely used neurologic agent that acts as a potent inhibitor of histone deacetylase activities. Here, we show that valproic acid addition to liquid cultures of human CD34+ cells isolated from cord blood, mobilized peripheral blood, and bone marrow strongly enhances the ex vivo expansion potential of different cytokine cocktails as shown by morphologic, cytochemical, immunophenotypical, clonogenic, and gene expression analyses. Notably, valproic acid highly preserves the CD34 positivity after 1 week (range, 40-89{\%}) or 3 weeks (range, 21-52{\%}) amplification cultures with two (Flt3L + thrombopoietin) or four cytokines (Flt3L + thrombopoietin + stem cell factor + interleukin 3). Moreover, valproic acid treatment increases histone H4 acetylation levels at specific regulatory sites on HOXB4, a transcription factor gene with a key role in the regulation of HSC self-renewal and AC133, a recognized marker gene for stem cell populations. Overall, our results relate the changes induced by valproic acid on chromatin accessibility with the enhancement of the cytokine effect on the maintenance and expansion of a primitive hematopoietic stem cell population. These findings underscore the potentiality of novel epigenetic approaches to modify HSC fate in vitro.",
author = "{De Felice}, Lidia and Caterina Tatarelli and Mascolo, {Maria Grazia} and Chiara Gregorj and Francesca Agostini and Roberto Fiorini and Vania Gelmetti and Simona Pascale and Fabrizio Padula and Petrucci, {Maria Teresa} and William Arcese and Clara Nervi",
year = "2005",
month = "2",
day = "15",
doi = "10.1158/0008-5472.CAN-04-3063",
language = "English",
volume = "65",
pages = "1505--1513",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "4",

}

TY - JOUR

T1 - Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells

AU - De Felice, Lidia

AU - Tatarelli, Caterina

AU - Mascolo, Maria Grazia

AU - Gregorj, Chiara

AU - Agostini, Francesca

AU - Fiorini, Roberto

AU - Gelmetti, Vania

AU - Pascale, Simona

AU - Padula, Fabrizio

AU - Petrucci, Maria Teresa

AU - Arcese, William

AU - Nervi, Clara

PY - 2005/2/15

Y1 - 2005/2/15

N2 - Ex vivo amplification of human hematopoietic stem cells (HSC) without loss of their self-renewing potential represents an important target for transplantation, gene and cellular therapies. Valproic acid is a safe and widely used neurologic agent that acts as a potent inhibitor of histone deacetylase activities. Here, we show that valproic acid addition to liquid cultures of human CD34+ cells isolated from cord blood, mobilized peripheral blood, and bone marrow strongly enhances the ex vivo expansion potential of different cytokine cocktails as shown by morphologic, cytochemical, immunophenotypical, clonogenic, and gene expression analyses. Notably, valproic acid highly preserves the CD34 positivity after 1 week (range, 40-89%) or 3 weeks (range, 21-52%) amplification cultures with two (Flt3L + thrombopoietin) or four cytokines (Flt3L + thrombopoietin + stem cell factor + interleukin 3). Moreover, valproic acid treatment increases histone H4 acetylation levels at specific regulatory sites on HOXB4, a transcription factor gene with a key role in the regulation of HSC self-renewal and AC133, a recognized marker gene for stem cell populations. Overall, our results relate the changes induced by valproic acid on chromatin accessibility with the enhancement of the cytokine effect on the maintenance and expansion of a primitive hematopoietic stem cell population. These findings underscore the potentiality of novel epigenetic approaches to modify HSC fate in vitro.

AB - Ex vivo amplification of human hematopoietic stem cells (HSC) without loss of their self-renewing potential represents an important target for transplantation, gene and cellular therapies. Valproic acid is a safe and widely used neurologic agent that acts as a potent inhibitor of histone deacetylase activities. Here, we show that valproic acid addition to liquid cultures of human CD34+ cells isolated from cord blood, mobilized peripheral blood, and bone marrow strongly enhances the ex vivo expansion potential of different cytokine cocktails as shown by morphologic, cytochemical, immunophenotypical, clonogenic, and gene expression analyses. Notably, valproic acid highly preserves the CD34 positivity after 1 week (range, 40-89%) or 3 weeks (range, 21-52%) amplification cultures with two (Flt3L + thrombopoietin) or four cytokines (Flt3L + thrombopoietin + stem cell factor + interleukin 3). Moreover, valproic acid treatment increases histone H4 acetylation levels at specific regulatory sites on HOXB4, a transcription factor gene with a key role in the regulation of HSC self-renewal and AC133, a recognized marker gene for stem cell populations. Overall, our results relate the changes induced by valproic acid on chromatin accessibility with the enhancement of the cytokine effect on the maintenance and expansion of a primitive hematopoietic stem cell population. These findings underscore the potentiality of novel epigenetic approaches to modify HSC fate in vitro.

UR - http://www.scopus.com/inward/record.url?scp=13944263926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13944263926&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-3063

DO - 10.1158/0008-5472.CAN-04-3063

M3 - Article

VL - 65

SP - 1505

EP - 1513

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 4

ER -